DENTSPLY SIRONA Inc.
$12.79
▼
-0.26%
2026-04-21 10:22:01
www.dentsplysirona.com
NMS: XRAY
Explore DENTSPLY SIRONA Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.61 B
Current Price
$12.79
52W High / Low
$17.18 / $9.85
Stock P/E
—
Book Value
$6.71
Dividend Yield
5.5%
ROCE
6.17%
ROE
-36.43%
Face Value
—
EPS
$-3
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
14,000
Beta
1
Debt / Equity
185
Current Ratio
1.51
Quick Ratio
1.03
Forward P/E
7.57
Price / Sales
0.64
Enterprise Value
$4.47 B
EV / EBITDA
7.48
EV / Revenue
1.21
Rating
Hold
Target Price
$14.39
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Hologic, Inc. | NOT FOUND | — | — | — | 9.77% | 10.86% | $76.07 / $51.9 | $23.51 |
| 2. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 3. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 4. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 5. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 6. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 7. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 961 M | 904 M | 936 M | 879 M | 905 M | — |
| Operating Profit | 25 M | 46 M | 110 M | 70 M | 9 M | — |
| Net Profit | -146 M | -427 M | -45 M | 20 M | -430 M | — |
| EPS in Rs | -0.73 | -2.14 | -0.23 | 0.1 | -2.15 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.68 B | 3.79 B | 3.96 B | 3.92 B |
| Operating Profit | 252 M | 188 M | 289 M | 364 M |
| Net Profit | -598 M | -910 M | -132 M | -950 M |
| EPS in Rs | -2.99 | -4.56 | -0.66 | -4.76 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.43 B | 5.75 B | 7.37 B | 7.64 B |
| Total Liabilities | 4.09 B | 3.81 B | 4.08 B | 3.83 B |
| Equity | 1.34 B | 1.94 B | 3.29 B | 3.81 B |
| Current Assets | 2.02 B | 1.75 B | 1.97 B | 1.89 B |
| Current Liabilities | 1.34 B | 1.59 B | 1.43 B | 1.17 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 235 M | 461 M | 377 M | 517 M |
| Investing CF | -132 M | -197 M | -89 M | -138 M |
| Financing CF | -80 M | -302 M | -307 M | -329 M |
| Free CF | 104 M | 281 M | 228 M | 368 M |
| Capex | -131 M | -180 M | -149 M | -149 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -4.34% | 1.1% | — | — |
| Earnings Growth % | -589.39% | 86.11% | — | — |
| Profit Margin % | -23.99% | -3.33% | -24.22% | — |
| Operating Margin % | 4.96% | 7.29% | 9.28% | — |
| Gross Margin % | 51.62% | 52.61% | 54.23% | — |
| EBITDA Margin % | -13.66% | 6.28% | -16.88% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-12-26 | $0.16 |
| 2025-09-26 | $0.16 |
| 2025-06-27 | $0.16 |
| 2025-03-28 | $0.16 |
| 2024-12-27 | $0.16 |
Stock Splits
No stock split history available.